Search
for
Sort by
Research 181–210 of 876
- Androgens and hair: a biological paradox
- Prevalence of hair shedding among women
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Equine Hoof Stem Progenitor Cells (HPC) CD29 + /Nestin + /K15 + – a Novel Dermal/epidermal Stem Cell Population With a Potential Critical Role for Laminitis Treatment
- Linking allergy to mercury to HLA and burning mouth syndrome
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- A study of androgenic signs and disorders in Greek female patients with acne
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- The Association of Polycystic Ovarian Syndrome Among Reproductive-Aged Women With Consumption of Junk Food in Jeddah, Saudi Arabia
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Contents
- External Validation of PCOS Questionnaire in Assessing Quality of Life in Females with PCOS Based on Lifestyle Changes with Therapeutic Measures like OC Pills and Metformin
- Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle
- Endocrine disruptors as risk factors for idiopathic premature thelarche in girls: A case-control study
- Efluvio anágeno. Hallazgos tricoscópicos
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Treatment of hyperandrogenic alopecia in women
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Management of acne
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- 46,XY DSD due to impaired androgen production
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare